Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Stifel analyst Dara Azar initiated coverage on Enliven Therapeutics Inc (NASDAQ:ELVN) with a Buy rating and announced a price target of $60. Enliven Therapeutics shares closed at $33.63 on Monday. See how other analysts view this stock.
- Truist Securities analyst Jasper Bibb initiated coverage on Grand Canyon Education Inc (NASDAQ:LOPE) with a Buy rating and announced a price target of $200. Grand Canyon Education shares closed at $148.59 on Monday. See how other analysts view this stock.
- Raymond James analyst RJ Milligan initiated coverage on FrontView REIT Inc (NYSE:FVR) with a Strong Buy rating and announced a price target of $22. FrontView shares closed at $18.99 on Monday. See how other analysts view this stock.
- BTIG analyst Tyler DiMatteo initiated coverage on Magnite Inc (NASDAQ:MGNI) with a Buy rating and announced a price target of $20. Magnite shares closed at $14.63 on Monday. See how other analysts view this stock.
Considering buying LOPE stock? Here’s what analysts think:
Photo via Shutterstock
Login to comment